Published 1999 | Version v1
Publication

GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly.

Additional details

Created:
March 31, 2023
Modified:
November 28, 2023